These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 20573444)
1. Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells. Jung EU; Yoon JH; Lee YJ; Lee JH; Kim BH; Yu SJ; Myung SJ; Kim YJ; Lee HS Cancer Lett; 2010 Dec; 298(1):9-15. PubMed ID: 20573444 [TBL] [Abstract][Full Text] [Related]
2. Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells. Lee JH; Yoon JH; Yu SJ; Chung GE; Jung EU; Kim HY; Kim BH; Choi DH; Myung SJ; Kim YJ; Kim CY; Lee HS Cancer Lett; 2010 Sep; 295(2):229-35. PubMed ID: 20350780 [TBL] [Abstract][Full Text] [Related]
3. Enhanced interleukin-2 diphtheria toxin conjugate-induced growth suppression in retinoic acid-treated hypoxic hepatocellular carcinoma cells. Kim BH; Yoon JH; Myung SJ; Lee JH; Lee SH; Lee SM; Lee HS Cancer Lett; 2009 Feb; 274(2):259-65. PubMed ID: 18986761 [TBL] [Abstract][Full Text] [Related]
4. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma. Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710 [TBL] [Abstract][Full Text] [Related]
5. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma. Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068 [TBL] [Abstract][Full Text] [Related]
6. Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model. Kwak MS; Yu SJ; Yoon JH; Lee SH; Lee SM; Lee JH; Kim YJ; Lee HS; Kim CY J Cancer Res Clin Oncol; 2015 Nov; 141(11):2037-45. PubMed ID: 25989942 [TBL] [Abstract][Full Text] [Related]
7. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711 [TBL] [Abstract][Full Text] [Related]
8. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells. Tak E; Lee S; Lee J; Rashid MA; Kim YW; Park JH; Park WS; Shokat KM; Ha J; Kim SS J Hepatol; 2011 Feb; 54(2):328-39. PubMed ID: 21056497 [TBL] [Abstract][Full Text] [Related]
9. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo. Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468 [TBL] [Abstract][Full Text] [Related]
10. Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma. Miao J; Chen GG; Chun SY; Chak EC; Lai PB Int J Oncol; 2004 Sep; 25(3):651-9. PubMed ID: 15289866 [TBL] [Abstract][Full Text] [Related]
11. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Yan X; Chua MS; Sun H; So S Cancer Lett; 2008 Apr; 262(1):133-42. PubMed ID: 18207320 [TBL] [Abstract][Full Text] [Related]
12. Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma. Al-Rawashdeh FY; Scriven P; Cameron IC; Vergani PV; Wyld L Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1099-105. PubMed ID: 20177386 [TBL] [Abstract][Full Text] [Related]
13. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828 [TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma. Sibold S; Roh V; Keogh A; Studer P; Tiffon C; Angst E; Vorburger SA; Weimann R; Candinas D; Stroka D FEBS Lett; 2007 Mar; 581(5):989-94. PubMed ID: 17316623 [TBL] [Abstract][Full Text] [Related]
17. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340 [TBL] [Abstract][Full Text] [Related]
18. Biological and clinical implications of retinoic acid-responsive genes in human hepatocellular carcinoma cells. Kanki K; Akechi Y; Ueda C; Tsuchiya H; Shimizu H; Ishijima N; Toriguchi K; Hatano E; Endo K; Hirooka Y; Shiota G J Hepatol; 2013 Nov; 59(5):1037-44. PubMed ID: 23831118 [TBL] [Abstract][Full Text] [Related]
19. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation. Lu WJ; Chua MS; Wei W; So SK Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. Gwak GY; Yoon JH; Kim KM; Lee HS; Chung JW; Gores GJ J Hepatol; 2005 Mar; 42(3):358-64. PubMed ID: 15710218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]